1. Nguyen, Maria, Wong, Yvette C, Ysselstein, Daniel, Severino, Alex, Krainc, Dimitri. 2018. Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease. In Trends in neurosciences, 42, 140-149. doi:10.1016/j.tins.2018.11.001. https://pubmed.ncbi.nlm.nih.gov/30509690/
2. Li, Bo, He, Yinghui, Han, Xue, Song, Zixuan, Ouyang, Ling. 2015. Aberrant promoter methylation of SH3GL2 gene in vulvar squamous cell carcinoma correlates with clinicopathological characteristics and HPV infection status. In International journal of clinical and experimental pathology, 8, 15442-7. doi:. https://pubmed.ncbi.nlm.nih.gov/26823912/
3. Shang, Chao, Guo, Yan, Fu, Shuang, Fu, Weineng, Sun, Kailai. . SH3GL2 gene participates in MEK-ERK signal pathway partly by regulating EGFR in the laryngeal carcinoma cell line Hep2. In Medical science monitor : international medical journal of experimental and clinical research, 16, BR168-73. doi:. https://pubmed.ncbi.nlm.nih.gov/20512084/
4. Tian, Zengjian, Yu, Shilong, Cai, Ruizhi, Liu, Qilun, Zhu, Yongzhao. 2024. SH3GL2 and MMP17 as lung adenocarcinoma biomarkers: a machine-learning based approach. In Biochemistry and biophysics reports, 38, 101693. doi:10.1016/j.bbrep.2024.101693. https://pubmed.ncbi.nlm.nih.gov/38571554/
5. Qu, Shengtao, Yao, Yilong, Shang, Chao, Li, Zhen, Liu, Yunhui. 2012. MicroRNA-330 is an oncogenic factor in glioblastoma cells by regulating SH3GL2 gene. In PloS one, 7, e46010. doi:10.1371/journal.pone.0046010. https://pubmed.ncbi.nlm.nih.gov/23029364/
6. . 2024. Retraction: MicroRNA-330 Is an Oncogenic Factor in Glioblastoma Cells by Regulating SH3GL2 Gene. In PloS one, 19, e0297950. doi:10.1371/journal.pone.0297950. https://pubmed.ncbi.nlm.nih.gov/38265996/
7. Majumdar, Shyama, Gong, Edward M, Di Vizio, Dolores, Rosenberg, Jonathan E, Adam, Rosalyn M. . Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior. In Neoplasia (New York, N.Y.), 15, 749-60. doi:. https://pubmed.ncbi.nlm.nih.gov/23814487/
智鼠故事 
